So as l and others have suggested big pharma are not interested in licencing any of the Dep trio after the phase 2 stage which is not the line the company has been reporting for years now.
This does not make me happy. You cannot tell me it's only since MC has taken on the job that the big pharma companies who were in discussions have suddenly taken this position. It appears that previously company announcements and presentations were inaccurate at best or misleading at worst.
Ann: Investor Webinar Notification - SPL Business Update, page-32
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |